RT Journal Article
SR Electronic
T1 CHARACTERIZING AND MANAGING AN EPIDEMIC: A FIRST PRINCIPLES MODEL AND A CLOSED FORM SOLUTION TO THE KERMACK AND MCKENDRICK EQUATIONS
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.09.21263355
DO 10.1101/2021.09.09.21263355
A1 Duclos, Ted
A1 Reichert, Tom
YR 2021
UL http://medrxiv.org/content/early/2021/09/14/2021.09.09.21263355.abstract
AB We derived a closed-form solution to the original epidemic equations formulated by Kermack and McKendrick in 1927 (1). The complete solution is validated using independently measured mobility data and accurate predictions of COVID-19 case dynamics in multiple countries. It replicates the observed phenomenology, quantitates pandemic dynamics, and provides simple analytical tools for policy makers. Of particular note, it projects that increased social containment measures shorten an epidemic and reduce the ultimate number of cases and deaths. In contrast, the widely used Susceptible–Infectious–Recovered (SIR) models, based on an approximation to Kermack and McKendrick’s original equations, project that strong containment measures delay the peak in daily infections, causing a longer epidemic. These projections contradict both the complete solution and the observed phenomenology in COVID-19 pandemic data. The closed-form solution elucidates that the two parameters classically used as constants in approximate SIR models cannot, in fact, be reasonably assumed to be constant in real epidemics. This prima facie failure forces the conclusion that the approximate SIR models should not be used to characterize or manage epidemics. As a replacement to the SIR models, the closed-form solution and the expressions derived from the solution form a complete set of analytical tools that can accurately diagnose the state of an epidemic and provide proper guidance for public health decision makers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was self fundedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be made available by the authors upon requestASIRapproximate SIRCSIRcomplete SIRRCOrate of change operatorRMMresidential mobility measureSIRsusceptible–Infectious–Recovered